Graham C, Girkin J, Bourgenot C. Spectral index selection method for remote moisture sensing under challenging illumination conditions. Sci Rep. 2022 Aug 25;12(1):14555. doi: 10.1038/s41598-022-18801-9
Hamadani M, Graham C, Liao L, Zhang K, Strat HM, Ungar D, Ai W, Chen L, Carlo-Stella C. Long-term survival projections of loncastuximab tesirine-treated patients in relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). J Clin Oncol. 2022 Jun;40(16_suppl):e19551.
Graham CN, Watson C, Barlev A, Stevenson M, Dharnidharka VT. Mean lifetime survival estimates following solid organ transplantation in the US and UK. J Med Econ. 2022 Jan;25(1):230-7. doi: 10.1080/13696998.2022.2033050
Graham CN, Davis KL, Goyal RK. Effect of sample size and data maturity on parametric survival modeling projections in advanced cancer. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.
Graham CN, Hechmati G, Hjelmgren J, de Liege F, Knoof A, Lanier J, Knox HN, Barber B, de Pouvourville G. Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type ras metastatic colorectal cancer. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.
Graham CN, Hechmati G, Hjelmgren J, de Liege F, Lanier J, Knox H, Barber B. Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer. Eur J Cancer. 2014 Nov;50(16):2791-801. doi: 10.1016/j.ejca.2014.08.016